OTLK
Outlook Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.39
-0.03 ▼ -6.41%
🌙 3월 13일 7:42 PM ET (한국 3/14 08:42)
$0.40
+0.01 ▲ +1.93%
| Index | - | P/E | - | EPS (ttm) | -1.09 | Insider Own | 30.67% | Shs Outstand | 0.06B | Perf Week | -4.83% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | 51.94% | Insider Trans | - | Shs Float | 0.06B | Perf Month | -16.06% |
| Enterprise Value | 0.06B | PEG | - | EPS next Q | -0.14 | Inst Own | 9.66% | Short Float | 6.41% | Perf Quarter | -81.15% |
| Income | -0.04B | P/S | 21.68 | EPS this Y | 63.97% | Inst Trans | 3.45% | Short Ratio | 0.66 | Perf Half Y | -63.85% |
| Sales | 0.00B | P/B | - | EPS next 5Y | 56.24% | ROA | -125.04% | Short Interest | 3.69M | Perf YTD | -75.06% |
| Book/sh | -0.6 | P/C | 3.77 | EPS past 3/5Y | 33.96% 33.18% | ROE | - | 52W High | -88.38% ($3.39) | Perf Year | -73.38% |
| Cash/sh | 0.1 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 3.66% ($0.38) | Perf 3Y | -98.11% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 86.28% | Gross Margin | 63.07% | Volatility(W/M) | 7.79% 9.14% | Perf 5Y | -99.12% |
| Dividend TTM | - | EV/Sales | 40.36 | Sales Y/Y TTM | - | Oper. Margin | -4824.52% | ATR (14) | 0.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.28 | EPS Q/Q | -260.86% | Profit Margin | -2885.82% | RSI (14) | 36.5 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.35 | Sales Q/Q | - | SMA20 | -7.77% ($0.42) | Beta | -0.08 | Target Price | $4.38 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | -19.93% ($0.49) | Rel Volume | 0.35 | Prev Close | $0.42 |
| Employees | 17 | LT Debt/Eq | - | EPS/Sales Surpr. | 2.96% -138.44% | SMA200 | -71.52% ($1.37) | Avg Volume(3M) | 5.58M | Price | $0.39 |
| IPO | 2016/6/14 | Option/Short | Yes/Yes | Trades | 2072 | Volume | 1,957,246 | Change | -6.41% |
뉴스 로딩 중...